News
Johnson & Johnson has decided to halt the development ... Neumora said navacaprant had failed the phase 3 KOASTAL-1 study in MDD, looking at depression symptoms, but had taken the learnings ...
For generations of Americans the Johnson & Johnson brand has been a beloved one, as quintessentially American as baseball and ...
An investigative history of the scandal-plagued company shines a light on a health care industry riddled with corruption and ...
In its first-quarter 2025 investor letter, Mar Vista U.S. Quality Select Strategy highlighted stocks such as Johnson & Johnson (NYSE:JNJ). Johnson & Johnson (NYSE:JNJ) is a multinational company ...
Is the Trump Administration About to Cause AbbVie, Eli Lilly, and Johnson & Johnson Stocks to Crash?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results